Protagenic Therapeutics (PTIX) — Cash Flow-to-Debt Ratio
Protagenic Therapeutics (PTIX) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of $-410.42K could theoretically repay 0% of its total liabilities ($6.82 Million) in one year. See how much free cash does Protagenic Therapeutics generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Protagenic Therapeutics Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Protagenic Therapeutics across 31 annual periods. Also explore Protagenic Therapeutics net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Protagenic Therapeutics (1995–2025)
Year-by-year debt coverage analysis for Protagenic Therapeutics. For market capitalisation and broader financial context, see Protagenic Therapeutics market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $942.76K | ▲ +20.9% |
| 2023 | -5.65x | $-3.70 Million | $655.25K | ▼ -217.5% |
| 2022 | -1.78x | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $684.86K | ▼ -210.1% |
| 2015 | -0.54x | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-790.00K | $316.00K | ▼ -13927.8% |
| 2012 | -0.02x | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.01x | $-11.25 Million | $11.17 Million | ▼ -543.1% |
| 2009 | -0.16x | $-3.02 Million | $19.25 Million | ▼ -186.7% |
| 2008 | 0.18x | $4.36 Million | $24.11 Million | ▲ +124.6% |
| 2007 | -0.73x | $-5.21 Million | $7.10 Million | ▼ -436.7% |
| 2006 | 0.22x | $931.00K | $4.27 Million | ▲ +146.8% |
| 2005 | -0.47x | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $4.21 Million | ▼ -193.6% |
| 2003 | 0.21x | $1.87 Million | $8.76 Million | ▼ -21.2% |
| 2002 | 0.27x | $2.35 Million | $8.65 Million | ▲ +74.9% |
| 2001 | 0.15x | $1.50 Million | $9.71 Million | ▼ -60.0% |
| 2000 | 0.39x | $3.51 Million | $9.06 Million | ▲ +1029.6% |
| 1999 | 0.03x | $331.00K | $9.66 Million | ▲ +159.5% |
| 1998 | -0.06x | $-434.00K | $7.53 Million | ▲ +93.5% |
| 1997 | -0.89x | $-2.20 Million | $2.47 Million | ▼ -2042.5% |
| 1996 | -0.04x | $-230.00K | $5.53 Million | ▲ +75.3% |
| 1995 | -0.17x | $-600.00K | $3.57 Million | — |